Warren Shawn Carbonell
InvestorFounderManaging Partner at Brazen Capital · Founder at OncoSynergy
Redondo Beach, California
Writes $100K – $5M checks · typically $1.5M
FoundedOncoSynergy
Find your path to Warren
1,344 people in our graph share verified history with Warren — schools, employers, funds. One of them is your warm intro.
About
Warren Shawn Carbonell is a founder and scientist who left a neurosurgery residency to develop a brain cancer therapeutic targeting integrins, raising $20 million to build a biotech company. His lead drug candidate completed Phase I clinical trials, and the integrin discovery was awarded the 2022 Lasker Prize. Beyond his primary venture, Carbonell has established a brain cancer nonprofit, launched a biotech VC fund, built a social media following, and contributed to community and event programming across multiple organizations.
Founder at OncoSynergy
Intro paths
In turn, Warren can intro founders to OncoSynergy's investors below.
OncoSynergy's investors · 2
Co-founders at OncoSynergy
Experience
- Stealth AI StartupFoundercurrent2025 — present
- Brazen CapitalCofounder & Managing Partnercurrent2021 — presentLos Angeles Metropolitan Area
- Brazen BioCofounder & CEOcurrent2021 — presentLos Angeles, California, United States
- Cure GlioblastomaCofounder & Presidentcurrent2019 — presentVenice, California
- The New Jersey 5s - Major League PickleballOperations2025New Jersey, United States
- OncoSynergyCofounder & Chief Scientific Officer2022 — 2025
- OncoSynergyCofounder & CEO2011 — 2019Stamford, Connecticut, United States
- UCSFPostdoctoral Scholar, Department of Neurological Surgery2010 — 2012
- University of OxfordNicholas Kurti Junior Fellow in Science2007 — 2010Brasenose College
- University of OxfordSenior Postdoctoral Fellow2006 — 2009
- Cedars-Sinai Medical CenterNeurosurgery Resident2009
- University of Virginia School of MedicineMedical Student (MSTP)1999 — 2006
- University of Virginia School of MedicineGraduate Researcher (MSTP)2000 — 2005
- University of WashingtonUndergraduate Researcher1995 — 1999
- NintendoGame Play Counselor/Consumer Service Rep1990 — 1991Redmond, Washington, United States
Skills & more
+6 more
Drug DiscoveryLifesciencesResearchCellScienceImmunohistochemistryFrom Warren's professional profile.
Colleagues at Brazen Capital
Frequently asked questions
- Who is Warren Shawn Carbonell?
- Warren Shawn Carbonell is a founder and scientist who left a neurosurgery residency to develop a brain cancer therapeutic targeting integrins, raising $20 million to build a biotech company. His lead drug candidate completed Phase I clinical trials, and the integrin discovery was awarded the 2022 Lasker Prize. Beyond his primary venture, Carbonell has established a brain cancer nonprofit, launched a biotech VC fund, built a social media following, and contributed to community and event programming across multiple organizations.
- Where does Warren Shawn Carbonell work?
- Warren Shawn Carbonell is Founder of OncoSynergy and Managing Partner at Brazen Capital.
- What check size does Warren Shawn Carbonell write?
- Warren Shawn Carbonell typically writes checks of $100K – $5M.
- What companies did Warren Shawn Carbonell found?
- Warren Shawn Carbonell founded OncoSynergy.
- Where did Warren Shawn Carbonell go to school?
- Warren Shawn Carbonell studied at University of Virginia School of Medicine (MD, Medicine); University of Virginia (PhD, Neuroscience); University of Washington (BS, Psychology).
Founder mafias
University of Virginia mafia190
Also came through, then founded or led a company.
+ 183 more
Nintendo mafia4
Also came through, then founded or led a company.
University of Virginia School of Medicine mafia3
Also came through, then founded or led a company.
Brazen Capital mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Virginia School of Medicine3
Also attended University of Virginia661
+ 655 more
Also attended University of Washington461
+ 455 more
Shared employers
Also worked at OncoSynergy1
Also worked at UCSF141
+ 135 more
Also worked at University of Oxford196
+ 190 more




































